Literature DB >> 18792393

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

Istvan Hritz1, Pranoti Mandrekar, Arumugam Velayudham, Donna Catalano, Angela Dolganiuc, Karen Kodys, Evelyn Kurt-Jones, Gyongyi Szabo.   

Abstract

UNLABELLED: The Toll-like receptor 4 (TLR4) that recognizes endotoxin, a trigger of inflammation in alcoholic liver disease (ALD), activates two signaling pathways utilizing different adapter molecules: the common TLR adapter, myeloid differentiation factor 88 (MyD88), or Toll/interleukin immune-response-domain-containing adaptor inducing interferon (IFN)-beta. The MyD88 pathway induces proinflammatory cytokine activation, a critical mediator of ALD. Here we evaluated the role of MyD88 in alcohol-induced liver injury in wild-type, TLR2-deficient, TLR4-deficient, or MyD88-deficient (knockout [KO]) mice after administration of the Lieber-De-Carli diet (4.5% volume/volume ethanol) or an isocaloric liquid control diet for 5 weeks. Alcohol feeding resulted in a significant increase in serum alanine aminotransferase levels, liver steatosis and triglyceride levels suggesting liver damage in WT, TLR2-KO, and MyD88-KO but not in TLR4-KO mice. Expression of inflammatory mediators (tumor necrosis factor-alpha and interleukin-6) and TLR4 coreceptors (CD14 and MD2) was significantly higher in livers of alcohol-fed WT, TLR2-KO, or MyD88-KO, but not in TLR4-KO mice, compared to controls. Reactive oxygen radicals produced by cytochrome P450 and the nicotinamide adenine dinucleotide phosphate complexes contribute to alcoholic liver damage. Alcohol feeding-induced expression and activation of cytochrome P450 and the nicotinamide adenine dinucleotide phosphate complex were prevented by TLR4-deficiency but not by MyD88-deficiency. Liver expression of interferon regulatory factor 3 (IRF3), a MyD88-independent signaling molecule, was not affected by chronic alcohol treatment in whole livers of WT mice or in any of the KO mice. However, the induction of IRF7, an IRF3-inducible gene, was found in Kupffer cells of alcohol-fed WT mice. Alcohol feeding also induced nuclear factor-kappaB activation in a TLR4-dependent MyD88-independent manner.
CONCLUSION: While TLR4 deficiency was protective, MyD88 deficiency failed to prevent alcohol-induced liver damage and inflammation. These results suggest that the common TLR adapter, MyD88, is dispensable in TLR4-mediated liver injury in ALD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792393      PMCID: PMC7137387          DOI: 10.1002/hep.22470

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

Review 1.  Pattern recognition receptors: a contemporary view on liver diseases.

Authors:  Gyongyi Szabo; Angela Dolganiuc; Pranoti Mandrekar
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

2.  Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria.

Authors:  F Stephen Laroux; Xavier Romero; Lee Wetzler; Pablo Engel; Cox Terhorst
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

3.  Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome P450 2E1 and 2A5.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

4.  Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

Authors:  Jordi Colmenero; Ramón Bataller; Pau Sancho-Bru; Pablo Bellot; Rosa Miquel; Montserrat Moreno; Pedro Jares; Jaime Bosch; Vicente Arroyo; Joan Caballería; Pere Ginès
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

5.  Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice.

Authors:  Takehiko Uesugi; Matthias Froh; Gavin E Arteel; Blair U Bradford; Michael D Wheeler; Erwin Gäbele; Fuyumi Isayama; Ronald G Thurman
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Cross-talk between IRAK-4 and the NADPH oxidase.

Authors:  Sandrine Pacquelet; Jennifer L Johnson; Beverly A Ellis; Agnieszka A Brzezinska; William S Lane; Daniela B Munafo; Sergio D Catz
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

7.  Reduced early alcohol-induced liver injury in CD14-deficient mice.

Authors:  M Yin; B U Bradford; M D Wheeler; T Uesugi; M Froh; S M Goyert; R G Thurman
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

Review 8.  Oxidants and antioxidants in alcohol-induced liver disease.

Authors:  Gavin E Arteel
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

9.  Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Qifang Wang; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2006-03-22       Impact factor: 4.962

Review 10.  Endotoxin and Kupffer cell activation in alcoholic liver disease.

Authors:  Michael D Wheeler
Journal:  Alcohol Res Health       Date:  2003
View more
  190 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2011-01-25       Impact factor: 3.362

4.  Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.

Authors:  Jan Petrasek; Angela Dolganiuc; Timea Csak; Bharath Nath; Istvan Hritz; Karen Kodys; Donna Catalano; Evelyn Kurt-Jones; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

5.  Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes.

Authors:  Nicholas A Floreani; Travis J Rump; P M Abdul Muneer; Saleena Alikunju; Brenda M Morsey; Michael R Brodie; Yuri Persidsky; James Haorah
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-09       Impact factor: 4.147

6.  Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure.

Authors:  Palash Mandal; Sanjoy Roychowdhury; Pil-Hoon Park; Brian T Pratt; Thierry Roger; Laura E Nagy
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

Review 7.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

8.  Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.

Authors:  Jan Petrasek; Angela Dolganiuc; Timea Csak; Evelyn A Kurt-Jones; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 9.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells.

Authors:  Yu-Feng Liu; Jian-Yang Wei; Mao-Hua Shi; Hua Jiang; Jie Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.